| Literature DB >> 31057103 |
Kota Kurisu1, Jong Youl Kim1,2, Jesung You1,3, Midori A Yenari1.
Abstract
Therapeutic hypothermia has consistently been shown to be a robust neuroprotectant in many labs studying different models of neurological disease. Although this therapy has shown great promise, there are still challenges at the clinical level that limit the ability to apply this routinely to each pathological condition. In order to overcome issues involved in hypothermia therapy, understanding of this attractive therapy is needed. We review methodological concerns surrounding therapeutic hypothermia, introduce the current status of therapeutic cooling in various acute brain insults, and review the literature surrounding the many underlying molecular mechanisms of hypothermic neuroprotection. Because recent work has shown that body temperature can be safely lowered using pharmacological approaches, this method may be an especially attractive option for many clinical applications. Since hypothermia can affect multiple aspects of brain pathophysiology, therapeutic hypothermia could also be considered a neuroprotection model in basic research, which would be used to identify potential therapeutic targets. We discuss how research in this area carries the potential to improve outcome from various acute neurological disorders. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Hypothermia; cardiac arrest; hypoxic-zzm321990ischemic encephalopathy; pharmacology induced hypothermia; stroke; traumatic brain injury.
Mesh:
Year: 2019 PMID: 31057103 PMCID: PMC6913523 DOI: 10.2174/0929867326666190506124836
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530